AGIO
AGIOS PHARMACEUTICALS, INC.
Company overview
- Market capitalization
- $2.00B
- Employees
- 539
- Latest publication
- 2026-09-29
About AGIOS PHARMACEUTICALS, INC.
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product is also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and AQVESME for the treatment of adult patients with non-transfusion dependent and transfusion-dependent alpha- or beta-thalassemia. In addition, it developed tebapivat, a PK activator for the treatment of lower-risk myelodysplastic syndrome and sickle cell disease; AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria (PKU); and AG-236, an siRNA in-licensed from Alnylam, targeting the transmembrane serine protease 6 (TMPRSS6) gene for the treatment of polycythemia vera. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q1 20202020-03-31 · USD | Q3 20192019-09-30 · USD | Q2 20192019-06-30 · USD | Q1 20192019-03-31 · USD | Q3 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 44,745,000USD | 10,730,000USD | 8,964,000USD | 87,098,000USD | 26,024,000USD | 26,221,000USD | 30,227,000USD | 15,198,000USD |
| Cost Of Revenue | 2,996,000USD | 1,260,000USD | 783,000USD | 533,000USD | 393,000USD | 303,000USD | 334,000USD | 695,000USD |
| Gross Profit | 41,749,000USD | 9,470,000USD | 8,181,000USD | 86,565,000USD | 25,631,000USD | 25,918,000USD | 29,893,000USD | 14,503,000USD |
| Research Development | 100,754,000USD | 82,810,000USD | 72,455,000USD | 91,256,000USD | 101,672,000USD | 107,389,000USD | 95,585,000USD | 82,561,000USD |
| Selling General Administrative | 51,547,000USD | 51,697,000USD | 38,537,000USD | 38,501,000USD | 33,019,000USD | 32,390,000USD | 31,791,000USD | 31,104,000USD |
| Total Operating Expenses | 152,301,000USD | 134,507,000USD | 110,992,000USD | 129,757,000USD | 134,691,000USD | 139,779,000USD | 127,376,000USD | 113,665,000USD |
| Operating Income | -110,552,000USD | -125,037,000USD | -102,811,000USD | -43,192,000USD | -109,060,000USD | -113,861,000USD | -97,483,000USD | -99,162,000USD |
| Total Other Income Expense Net | 119,000USD | 19,638,000USD | 1,103,846,000USD | -40,902,000USD | 2,887,000USD | 3,990,000USD | 4,405,000USD | 4,498,000USD |
| Net Income | -100,703,000USD | -96,523,000USD | 947,915,000USD | -40,256,000USD | -106,173,000USD | -109,871,000USD | -93,078,000USD | -94,664,000USD |
| Interest Income | — | 18,015,000USD | 13,059,000USD | 2,936,000USD | 2,887,000USD | 3,990,000USD | 4,405,000USD | — |
| Net Interest Income | — | 18,015,000USD | 13,059,000USD | 2,936,000USD | 2,887,000USD | 3,990,000USD | 4,405,000USD | — |
| Income Before Tax | — | -105,399,000USD | 1,001,035,000USD | -84,094,000USD | -106,173,000USD | -109,871,000USD | -93,078,000USD | -94,664,000USD |
| Income Tax Expense | — | -8,876,000USD | 53,120,000USD | — | — | — | — | 0USD |
| Tax Provision | — | -8,876,000USD | 53,120,000USD | — | — | — | — | — |
| Net Income From Continuing Ops | — | -96,523,000USD | 947,915,000USD | -40,256,000USD | -106,173,000USD | -109,871,000USD | -93,078,000USD | -94,664,000USD |
| Ebit | — | -105,399,000USD | 1,001,035,000USD | -40,256,000USD | -106,173,000USD | -109,871,000USD | -97,483,000USD | -99,162,000USD |
| Ebitda | — | -104,032,000USD | 1,002,380,000USD | -37,782,000USD | -104,091,000USD | -107,834,000USD | -95,478,000USD | -97,365,000USD |
| Depreciation And Amortization | — | 1,367,000USD | 1,345,000USD | 2,474,000USD | 2,082,000USD | 2,037,000USD | 2,005,000USD | 1,797,000USD |
| Reconciled Depreciation | — | 1,367,000USD | 1,345,000USD | 2,474,000USD | 2,082,000USD | 2,037,000USD | 2,005,000USD | 1,797,000USD |
| Interest Expense | — | — | — | 2,936,000USD | 2,887,000USD | 3,990,000USD | 4,405,000USD | 4,498,000USD |
| Non Operating Income Net Other | — | — | — | 2,936,000USD | 2,887,000USD | 3,990,000USD | 4,405,000USD | 4,498,000USD |
| Net Income Applicable To Common Shares | — | — | — | -40,256,000USD | -106,173,000USD | -109,871,000USD | -93,078,000USD | -94,664,000USD |
| Minority Interest | — | — | — | — | — | — | — | 0USD |
| Discontinued Operations | — | — | — | — | — | — | — | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD | FY 20112011-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 36,498,000USD | 59,119,000USD | 65,358,000USD | 25,548,000USD | 25,106,000USD | 21,837,000USD |
| Cost Of Revenue | 4,165,000USD | 141,827,000USD | 118,124,000USD | 62,991,000USD | 41,037,000USD | 37,667,000USD |
| Gross Profit | 32,333,000USD | 59,119,000USD | 65,358,000USD | 25,548,000USD | -15,931,000USD | 21,837,000USD |
| Research Development | 301,286,000USD | 141,827,000USD | 100,371,000USD | 54,502,000USD | 41,037,000USD | 31,253,000USD |
| Selling General Administrative | 156,784,000USD | 35,992,000USD | 19,120,000USD | 9,929,000USD | 7,064,000USD | 7,215,000USD |
| Total Operating Expenses | 458,070,000USD | 177,819,000USD | 119,491,000USD | 64,431,000USD | 48,101,000USD | 38,468,000USD |
| Operating Income | -425,737,000USD | -118,700,000USD | -54,133,000USD | -38,883,000USD | -22,995,000USD | -16,631,000USD |
| Interest Income | 48,083,000USD | 968,000USD | — | — | — | — |
| Net Interest Income | 48,083,000USD | — | — | — | — | — |
| Income Before Tax | 717,969,000USD | -117,732,000USD | -53,930,000USD | -38,828,000USD | -22,926,000USD | -16,499,000USD |
| Income Tax Expense | 44,244,000USD | -426,000USD | -426,000USD | 579,000USD | -2,824,000USD | 7,207,000USD |
| Tax Provision | 44,244,000USD | — | — | — | — | — |
| Net Income | 673,725,000USD | -117,732,000USD | -53,504,000USD | -39,407,000USD | -20,102,000USD | -23,706,000USD |
| Net Income From Continuing Ops | 673,725,000USD | -117,732,000USD | -53,504,000USD | -39,407,000USD | — | — |
| Ebit | 717,969,000USD | -118,700,000USD | -54,133,000USD | -38,883,000USD | -22,995,000USD | -16,631,000USD |
| Ebitda | 723,622,000USD | -115,358,000USD | -52,766,000USD | -37,443,000USD | -21,816,000USD | -15,830,000USD |
| Depreciation And Amortization | 5,653,000USD | 3,342,000USD | 1,367,000USD | 1,440,000USD | 1,179,000USD | 801,000USD |
| Reconciled Depreciation | 5,653,000USD | — | — | — | — | — |
| Total Other Income Expense Net | 1,143,706,000USD | 968,000USD | 203,000USD | 55,000USD | 69,000USD | 132,000USD |
| Interest Expense | — | 968,000USD | 203,000USD | 55,000USD | 69,000USD | 132,000USD |
| Non Operating Income Net Other | — | 968,000USD | 203,000USD | 55,000USD | — | — |
| Net Income Applicable To Common Shares | — | -117,732,000USD | -53,504,000USD | -43,569,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,108,424,000USD | 1,184,990,000USD | 1,297,225,000USD | 1,385,705,000USD | 1,471,237,000USD | 1,555,518,000USD | 1,663,199,000USD | 1,791,794,000USD |
| Cash And Equivalents | 99,647,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 717,668,000USD | 834,843,000USD | 942,052,000USD | 1,033,109,000USD | 1,019,464,000USD | 968,616,000USD | 965,600,000USD | 1,074,189,000USD |
| Other Current Assets | 45,724,000USD | 46,586,000USD | 44,130,000USD | 43,186,000USD | 44,693,000USD | 42,292,000USD | 40,165,000USD | 39,885,000USD |
| Other Non Current Assets | 9,681,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 82,403,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 70,217,000USD | 58,845,000USD | 82,206,000USD | 74,757,000USD | 70,410,000USD | 52,366,000USD | 81,156,000USD | 119,451,000USD |
| Other Current Liabilities | 34,647,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 240,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 1,026,021,000USD | 1,109,115,000USD | 1,193,114,000USD | 1,284,330,000USD | 1,369,555,000USD | 1,466,528,000USD | 1,540,956,000USD | 1,626,672,000USD |
| Total Equity Including Noncontrolling Interest | 1,026,021,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 33,821,000USD | 37,762,000USD | 41,229,000USD | 44,325,000USD | 47,364,000USD | 50,928,000USD | 54,554,000USD | 57,660,000USD |
| Accounts Payable | 16,345,000USD | 13,747,000USD | 18,355,000USD | 19,553,000USD | 17,532,000USD | 13,726,000USD | 16,643,000USD | 17,143,000USD |
| Short Term Debt | 19,225,000USD | 18,805,000USD | 18,392,000USD | 17,987,000USD | 17,589,000USD | 17,196,000USD | 16,781,000USD | 16,319,000USD |
| Retained Earnings | -761,519,000USD | -660,816,000USD | -561,705,000USD | -453,666,000USD | -350,233,000USD | -238,213,000USD | -148,924,000USD | -52,401,000USD |
| Total Liab | — | 75,875,000USD | 104,111,000USD | 101,375,000USD | 101,682,000USD | 88,990,000USD | 122,243,000USD | 165,122,000USD |
| Other Current Liab | — | 26,293,000USD | 45,459,000USD | 37,217,000USD | 35,289,000USD | 20,761,000USD | 46,861,000USD | 33,307,000USD |
| Common Stock | — | 76,000USD | 75,000USD | 74,000USD | 74,000USD | 74,000USD | 73,000USD | 73,000USD |
| Capital Stock | — | 0USD | 75,000USD | 74,000USD | 74,000USD | 74,000USD | 73,000USD | 73,000USD |
| Cash | — | 113,600,000USD | 89,130,000USD | 92,710,000USD | 80,871,000USD | 78,964,000USD | 76,247,000USD | 253,730,000USD |
| Cash And Short Term Investments | — | 737,038,000USD | 854,425,000USD | 952,860,000USD | 938,937,000USD | 893,375,000USD | 893,710,000USD | 1,004,757,000USD |
| Net Debt | — | -77,855,000USD | -48,923,000USD | -48,195,000USD | -32,111,000USD | -26,024,000USD | -19,259,000USD | -192,896,000USD |
| Short Long Term Debt Total | — | 35,745,000USD | 40,207,000USD | 44,515,000USD | 48,760,000USD | 52,940,000USD | 56,988,000USD | 60,834,000USD |
| Short Term Investments | — | 623,438,000USD | 765,295,000USD | 860,150,000USD | 858,066,000USD | 814,411,000USD | 817,463,000USD | 751,027,000USD |
| Net Receivables | — | 16,132,000USD | 10,577,000USD | 5,029,000USD | 4,986,000USD | 3,344,000USD | 4,109,000USD | 3,118,000USD |
| Inventory | — | 35,087,000USD | 32,920,000USD | 32,034,000USD | 30,848,000USD | 29,605,000USD | 27,616,000USD | 26,429,000USD |
| Accumulated Other Comprehensive Income | — | -314,000USD | 2,193,000USD | 2,051,000USD | 655,000USD | 365,000USD | -1,518,000USD | 3,420,000USD |
| Common Stock Shares Outstanding | — | 58,782,241shares | 58,329,899shares | 58,139,277shares | 57,932,576shares | 57,459,195shares | 57,156,000shares | 58,433,000shares |
| Non Current Assets Total | — | 350,147,000USD | 355,173,000USD | 352,596,000USD | 451,773,000USD | 586,902,000USD | 697,599,000USD | 717,605,000USD |
| Non Current Liabilities Total | — | 17,030,000USD | 21,905,000USD | 26,618,000USD | 31,272,000USD | 36,624,000USD | 41,087,000USD | 45,671,000USD |
| Non Current Liabilities Other | — | 17,030,000USD | 90,000USD | 90,000USD | 101,000USD | 880,000USD | 880,000USD | 1,156,000USD |
| Non Currrent Assets Other | — | 3,931,000USD | 3,931,000USD | 3,930,000USD | 3,942,000USD | 4,721,000USD | 4,724,000USD | 4,056,000USD |
| Net Working Capital | — | 775,998,000USD | 859,846,000USD | 958,352,000USD | 949,054,000USD | 916,250,000USD | 884,444,000USD | 954,738,000USD |
| Unclassified Non Current Assets | — | 308,454,000USD | — | — | — | — | — | — |
| Unclassified Equity | — | 1,770,169,000USD | 1,752,476,000USD | 1,735,797,000USD | 1,718,985,000USD | 1,704,228,000USD | 1,691,252,000USD | 1,675,507,000USD |
| Long Term Investments | — | — | 310,013,000USD | 304,341,000USD | 400,467,000USD | 531,253,000USD | 638,321,000USD | 655,889,000USD |
| Property Plant Equipment Gross | — | — | 101,344,000USD | 44,325,000USD | 47,364,000USD | 50,928,000USD | 111,051,000USD | 57,660,000USD |
| Unclassified Non Current Liabilities | — | — | 21,815,000USD | 26,528,000USD | 31,171,000USD | 35,744,000USD | 40,207,000USD | 44,515,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | 52,682,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,297,225,000USD | 1,663,199,000USD | 937,118,000USD | 1,238,718,000USD | 1,437,736,000USD | 852,952,000USD | 890,741,000USD | 858,457,000USD |
| Other Current Assets | 44,130,000USD | 40,165,000USD | 35,021,000USD | 38,955,000USD | 39,835,000USD | 63,748,000USD | 24,177,000USD | 17,167,000USD |
| Total Liab | 104,111,000USD | 122,243,000USD | 126,099,000USD | 137,904,000USD | 145,761,000USD | 453,452,000USD | 250,213,000USD | 170,920,000USD |
| Total Stockholder Equity | 1,193,114,000USD | 1,540,956,000USD | 811,019,000USD | 1,100,814,000USD | 1,291,975,000USD | 399,500,000USD | 640,528,000USD | 687,537,000USD |
| Other Current Liab | 45,459,000USD | 46,861,000USD | 43,167,000USD | 30,350,000USD | 31,967,000USD | 69,260,000USD | 53,142,000USD | 42,913,000USD |
| Common Stock | 75,000USD | 73,000USD | 72,000USD | 71,000USD | 71,000USD | 69,000USD | 68,000USD | 58,000USD |
| Capital Stock | 75,000USD | 73,000USD | 72,000USD | 71,000USD | 71,000USD | 69,000USD | 68,000USD | 58,000USD |
| Retained Earnings | -561,705,000USD | -148,924,000USD | -822,649,000USD | -470,561,000USD | -238,760,000USD | -1,843,475,000USD | -1,516,105,000USD | -1,104,633,000USD |
| Cash | 89,130,000USD | 76,247,000USD | 88,205,000USD | 139,259,000USD | 203,126,000USD | 127,436,000USD | 80,931,000USD | 805,421,000USD |
| Cash And Short Term Investments | 854,425,000USD | 893,710,000USD | 776,928,000USD | 783,119,000USD | 1,020,018,000USD | 572,929,000USD | 564,877,000USD | 805,421,000USD |
| Total Current Assets | 942,052,000USD | 965,600,000USD | 833,835,000USD | 832,772,000USD | 1,064,231,000USD | 636,677,000USD | 611,704,000USD | 613,780,000USD |
| Total Current Liabilities | 82,206,000USD | 81,156,000USD | 67,955,000USD | 62,629,000USD | 59,826,000USD | 94,394,000USD | 92,886,000USD | 93,503,000USD |
| Net Debt | -27,108,000USD | -19,259,000USD | -16,209,000USD | -53,600,000USD | -106,032,000USD | -22,237,000USD | 32,731,000USD | -805,421,000USD |
| Short Term Debt | 18,392,000USD | 16,781,000USD | 15,008,000USD | 13,663,000USD | 11,159,000USD | 7,410,000USD | 6,915,000USD | 59,809,000USD |
| Short Long Term Debt Total | 62,022,000USD | 56,988,000USD | 71,996,000USD | 85,659,000USD | 97,094,000USD | 105,199,000USD | 113,662,000USD | — |
| Long Term Investments | 310,013,000USD | 638,321,000USD | 29,435,000USD | 313,874,000USD | 266,375,000USD | 97,608,000USD | 152,929,000USD | 220,119,000USD |
| Short Term Investments | 765,295,000USD | 817,463,000USD | 688,723,000USD | 643,860,000USD | 816,892,000USD | 445,493,000USD | 483,946,000USD | 514,800,000USD |
| Net Receivables | 10,577,000USD | 4,109,000USD | 2,810,000USD | 2,206,000USD | 4,378,000USD | 25,399,000USD | 15,319,000USD | 10,442,000USD |
| Inventory | 32,920,000USD | 27,616,000USD | 19,076,000USD | 8,492,000USD | 16,190,000USD | 14,698,000USD | 7,331,000USD | 869,000USD |
| Accounts Payable | 18,355,000USD | 16,643,000USD | 9,780,000USD | 18,616,000USD | 16,700,000USD | 17,724,000USD | 21,896,000USD | 17,880,000USD |
| Property Plant Equipment Net | 41,229,000USD | 54,554,000USD | 69,791,000USD | 88,116,000USD | 104,230,000USD | 116,066,000USD | 126,108,000USD | 24,320,000USD |
| Property Plant Equipment Gross | 101,344,000USD | 111,051,000USD | 122,020,000USD | 138,186,000USD | 28,923,000USD | 117,542,000USD | 31,472,000USD | 24,320,000USD |
| Accumulated Other Comprehensive Income | 2,193,000USD | -1,518,000USD | -441,000USD | -12,535,000USD | -1,198,000USD | 105,000USD | 202,000USD | -2,171,000USD |
| Common Stock Shares Outstanding | 57,972,004shares | 57,889,000shares | 55,651,487shares | 54,789,435shares | 60,447,346shares | 68,997,879shares | 59,994,539shares | 57,418,300shares |
| Non Current Assets Total | 355,173,000USD | 697,599,000USD | 103,283,000USD | 405,946,000USD | 373,505,000USD | 216,274,999USD | 279,037,000USD | 244,677,000USD |
| Non Current Liabilities Total | 21,905,000USD | 41,087,000USD | 58,144,000USD | 75,275,000USD | 85,935,000USD | 359,058,000USD | 157,327,000USD | 77,417,000USD |
| Non Current Liabilities Other | 90,000USD | 880,000USD | 1,156,000USD | 3,279,000USD | 85,935,000USD | 359,058,000USD | 157,327,000USD | 59,809,000USD |
| Non Currrent Assets Other | 3,931,000USD | 4,724,000USD | 4,057,000USD | 3,956,000USD | 2,900,000USD | 2,600,999USD | -279,037,000USD | 238,000USD |
| Net Working Capital | 859,846,000USD | 884,444,000USD | 765,880,000USD | 770,143,000USD | 1,004,405,000USD | 542,283,000USD | 518,818,000USD | 520,277,000USD |
| Unclassified Non Current Liabilities | 21,815,000USD | 40,207,000USD | 56,988,000USD | 68,717,000USD | — | -261,269,000USD | -50,580,000USD | -77,417,000USD |
| Unclassified Equity | 1,752,476,000USD | 1,691,252,000USD | 1,633,965,000USD | 2,386,254,000USD | 2,334,277,000USD | 2,242,732,000USD | 2,156,295,000USD | 1,794,225,000USD |
| Current Deferred Revenue | — | -16,781,000USD | — | — | — | — | 10,933,000USD | 92,519,000USD |
| Other Liab | — | — | — | 3,279,000USD | — | 261,269,000USD | 50,580,000USD | 77,417,000USD |
| Other Assets | — | — | — | 3,956,000USD | 2,900,000USD | 1,125,000USD | — | 238,000USD |
| Treasury Stock | — | — | — | -802,486,000USD | -802,486,000USD | — | — | — |
| Net Tangible Assets | — | — | — | 1,100,814,000USD | 1,291,975,000USD | 399,500,000USD | 640,528,000USD | 687,537,000USD |
| Unclassified Current Assets | — | — | — | — | -16,190,000USD | -40,097,000USD | — | -734,919,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 17,608,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | — | -119,618,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -99,111,000USD | -108,039,000USD | -103,433,000USD | -112,020,000USD | -89,289,000USD | -96,523,000USD | 947,915,000USD | -96,118,000USD |
| Depreciation | 1,363,000USD | 1,266,000USD | 1,374,000USD | 1,259,000USD | 1,278,000USD | 1,367,000USD | 1,345,000USD | 1,593,000USD |
| Stock Based Compensation | 15,541,000USD | 14,124,000USD | 12,377,000USD | 14,692,000USD | 11,359,000USD | 10,903,000USD | 11,145,000USD | 11,565,000USD |
| Other Non Cash Items | 2,086,000USD | 1,026,000USD | 1,762,000USD | 10,661,000USD | 1,668,000USD | -2,653,000USD | -1,089,976,000USD | 246,000USD |
| Change To Account Receivables | -5,555,000USD | -5,548,000USD | -43,000USD | -1,642,000USD | 765,000USD | -991,000USD | 644,000USD | -309,000USD |
| Change To Inventory | -2,167,000USD | -886,000USD | -1,186,000USD | -1,243,000USD | -1,989,000USD | -1,187,000USD | -2,492,000USD | -867,000USD |
| Change In Working Capital | -38,799,000USD | -4,590,000USD | -231,000USD | 8,284,000USD | -36,505,000USD | -46,261,000USD | 45,353,000USD | 10,125,000USD |
| Total Cash From Operating Activities | -118,920,000USD | -96,213,000USD | -88,151,000USD | -77,124,000USD | -111,489,000USD | -133,167,000USD | -84,218,000USD | -72,589,000USD |
| Capital Expenditures | -769,000USD | -1,120,000USD | -1,555,000USD | -875,000USD | -766,000USD | -967,000USD | -419,000USD | -158,000USD |
| Free Cash Flow | -119,689,000USD | -97,333,000USD | -89,706,000USD | -77,999,000USD | -112,255,000USD | -134,134,000USD | -84,637,000USD | -72,747,000USD |
| Investments | 142,081,000USD | 91,196,000USD | 95,555,000USD | 78,966,000USD | 112,587,000USD | -49,158,000USD | 250,793,000USD | 37,244,000USD |
| Total Cashflows From Investing Activities | 141,312,000USD | 90,076,000USD | 95,555,000USD | 78,966,000USD | 112,587,000USD | -49,158,000USD | 250,793,000USD | 37,244,000USD |
| Total Cash From Financing Activities | 2,078,000USD | 2,557,000USD | 4,435,000USD | 65,000USD | 1,619,000USD | 4,842,000USD | 2,637,000USD | 1,099,000USD |
| Change In Cash | 24,470,000USD | -3,580,000USD | 11,839,000USD | 1,907,000USD | 2,717,000USD | -177,483,000USD | 169,212,000USD | -34,246,000USD |
| Begin Period Cash Flow | 89,130,000USD | 92,710,000USD | 80,871,000USD | 78,964,000USD | 76,247,000USD | 253,730,000USD | 84,518,000USD | 118,764,000USD |
| End Period Cash Flow | 113,600,000USD | 89,130,000USD | 92,710,000USD | 80,871,000USD | 78,964,000USD | 76,247,000USD | 253,730,000USD | 84,518,000USD |
| Other Cashflows From Financing Activities | 2,078,000USD | — | 4,435,000USD | 65,000USD | 1,619,000USD | 4,842,000USD | 2,637,000USD | 1,099,000USD |
| Unclassified Investing Cash Flow | — | — | 1,555,000USD | 10,875,000USD | — | — | -1,088,757,000USD | -37,244,000USD |
| Other Cashflows From Investing Activities | — | — | — | -10,000,000USD | — | — | 1,089,176,000USD | 37,402,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -412,781,000USD | 673,725,000USD | -352,088,000USD | -231,801,000USD | -356,510,000USD | -329,305,000USD | -411,472,000USD | -346,028,000USD |
| Depreciation | 5,177,000USD | 5,653,000USD | 6,623,000USD | 8,564,000USD | 9,240,000USD | 18,772,000USD | 8,087,000USD | 7,172,000USD |
| Stock Based Compensation | 52,552,000USD | 42,847,000USD | 44,766,000USD | 49,296,000USD | 53,508,000USD | 61,602,000USD | 72,373,000USD | 73,357,000USD |
| Other Non Cash Items | 15,117,000USD | -1,092,298,000USD | 23,694,000USD | -119,104,000USD | -76,736,000USD | 17,809,000USD | 8,532,000USD | -3,817,000USD |
| Change To Account Receivables | -6,468,000USD | -1,299,000USD | -604,000USD | -2,206,000USD | -4,378,000USD | -10,060,000USD | -3,619,000USD | -6,102,000USD |
| Change To Inventory | -5,304,000USD | -8,540,000USD | -10,584,000USD | -8,492,000USD | 4,378,000USD | -7,367,000USD | -6,462,000USD | -869,000USD |
| Change In Working Capital | -33,042,000USD | -19,768,000USD | -19,057,000USD | -16,433,000USD | -36,822,000USD | 1,965,000USD | -45,999,000USD | -35,105,000USD |
| Total Cash From Operating Activities | -372,977,000USD | -389,841,000USD | -296,062,000USD | -309,478,000USD | -407,320,000USD | -290,759,000USD | -370,622,000USD | -304,421,000USD |
| Capital Expenditures | -4,316,000USD | -1,685,000USD | -999,000USD | -4,881,000USD | -5,741,000USD | -14,106,000USD | -12,171,000USD | -6,986,000USD |
| Free Cash Flow | -377,293,000USD | -391,526,000USD | -297,061,000USD | -314,359,000USD | -413,061,000USD | -304,865,000USD | -382,793,000USD | -311,407,000USD |
| Investments | 391,500,000USD | 363,441,000USD | 239,575,000USD | 243,261,000USD | -548,417,000USD | 90,655,000USD | 103,611,000USD | -266,839,000USD |
| Total Cashflows From Investing Activities | 377,184,000USD | 363,441,000USD | 239,575,000USD | 243,261,000USD | 1,248,778,000USD | 75,746,000USD | 91,440,000USD | -273,825,000USD |
| Total Cash From Financing Activities | 8,676,000USD | 14,442,000USD | 5,433,000USD | 2,350,000USD | -765,768,000USD | 261,517,999USD | 289,611,000USD | 546,024,000USD |
| Change In Cash | 12,883,000USD | -11,958,000USD | -51,054,000USD | -63,867,000USD | 75,690,000USD | 46,505,000USD | 10,429,000USD | -32,222,000USD |
| Begin Period Cash Flow | 76,247,000USD | 88,205,000USD | 139,259,000USD | 203,126,000USD | 127,436,000USD | 80,931,000USD | 70,502,000USD | 102,724,000USD |
| End Period Cash Flow | 89,130,000USD | 76,247,000USD | 88,205,000USD | 139,259,000USD | 203,126,000USD | 127,436,000USD | 80,931,000USD | 70,502,000USD |
| Other Cashflows From Investing Activities | -10,000,000USD | 1,089,136,000USD | -16,175,000USD | 1USD | 1,802,936,000USD | -803,000USD | 103,468,000USD | -266,839,000USD |
| Other Cashflows From Financing Activities | 8,676,000USD | 14,442,000USD | 5,433,000USD | 2,681,000USD | 37,296,000USD | 250,536,999USD | 12,523,000USD | 29,818,000USD |
| Net Borrowings | — | 0USD | 0USD | -331,000USD | -578,000USD | -336,000USD | -113,000USD | -113,000USD |
| Unclassified Investing Cash Flow | — | -1,087,451,000USD | 17,174,000USD | 4,880,999USD | — | — | -103,468,000USD | 266,839,000USD |
| Sale Purchase Of Stock | — | — | 0USD | 2,681,000USD | -802,486,000USD | 11,317,000USD | 289,724,000USD | 546,024,000USD |
| Change To Liabilities | — | — | — | 4,822,000USD | 1,929,000USD | 16,649,000USD | 10,949,000USD | 3,135,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -63,867,000USD | 75,690,000USD | 46,505,000USD | 10,429,000USD | -32,222,000USD |
| Unclassified Financing Cash Flow | — | — | — | -2,681,000USD | 37,296,000USD | — | -12,523,000USD | -29,705,000USD |
| Dividends Paid | — | — | — | — | -37,296,000USD | — | — | — |
| Issuance Of Capital Stock | — | — | — | — | 0USD | 0USD | 277,201,000USD | 516,206,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | -61,602,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2024Yearly · 2024-12-31 | Product | Product | 36,498,000 | USD | 0001439222-25-000009 |
| FY 2024Yearly · 2024-12-31 | Product | Royalty | 0 | USD | 0001439222-25-000009 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 26,823,000 | USD | 0001439222-25-000009 |
| FY 2023Yearly · 2023-12-31 | Product | Royalty | 0 | USD | 0001439222-25-000009 |
| Q3 2023Quarterly · 2023-09-30 | Product | Product | 7,399,000 | USD | 0001439222-23-000140 |
| Q3 2023Quarterly · 2023-09-30 | Product | Royalty | 0 | USD | 0001439222-23-000140 |
| Q2 2023Quarterly · 2023-06-30 | Product | Product | 6,712,000 | USD | 0001439222-23-000119 |
| Q2 2023Quarterly · 2023-06-30 | Product | Royalty | 0 | USD | 0001439222-23-000119 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 11,740,000 | USD | 0001439222-25-000009 |
| FY 2022Yearly · 2022-12-31 | Product | Royalty | 2,500,000 | USD | 0001439222-25-000009 |
| Q3 2022Quarterly · 2022-09-30 | Product | Product | 3,516,000 | USD | 0001439222-23-000140 |
| Q3 2022Quarterly · 2022-09-30 | Product | Royalty | 0 | USD | 0001439222-23-000140 |
| Q2 2022Quarterly · 2022-06-30 | Product | Product | 3,082,000 | USD | 0001439222-23-000119 |
| Q2 2022Quarterly · 2022-06-30 | Product | Royalty | 2,500,000 | USD | 0001439222-23-000119 |
| Q3 2020Quarterly · 2020-09-30 | Product | Collaboration Revenue Related Party — Commercialization Activity | 1,007,000 | USD | 0001439222-20-000069 |
| Q3 2020Quarterly · 2020-09-30 | Product | Collaboration Revenue Related Party — Research Services | 199,000 | USD | 0001439222-20-000069 |
| Q3 2020Quarterly · 2020-09-30 | Product | License And Service | 0 | USD | 0001439222-20-000069 |
| Q3 2020Quarterly · 2020-09-30 | Product | Other | 1,101,000 | USD | 0001439222-20-000069 |
| Q3 2020Quarterly · 2020-09-30 | Product | Product | 31,716,000 | USD | 0001439222-20-000069 |
| Q3 2020Quarterly · 2020-09-30 | Product | Royalty | 683,000 | USD | 0001439222-20-000069 |
| Q2 2020Quarterly · 2020-06-30 | Product | Collaboration Revenue Related Party — Commercialization Activity | 1,021,000 | USD | 0001439222-20-000059 |
| Q2 2020Quarterly · 2020-06-30 | Product | Collaboration Revenue Related Party — Research Services | 4,714,000 | USD | 0001439222-20-000059 |
| Q2 2020Quarterly · 2020-06-30 | Product | License And Service | 0 | USD | 0001439222-20-000059 |
| Q2 2020Quarterly · 2020-06-30 | Product | Other | 731,000 | USD | 0001439222-20-000059 |
| Q2 2020Quarterly · 2020-06-30 | Product | Product | 27,581,000 | USD | 0001439222-20-000059 |
| Q2 2020Quarterly · 2020-06-30 | Product | Royalty | 3,300,000 | USD | 0001439222-20-000059 |
| Q1 2020Quarterly · 2020-03-31 | Product | Collaboration Revenue Other | 993,000 | USD | 0001439222-20-000039 |
| Q1 2020Quarterly · 2020-03-31 | Product | Collaboration Revenue Related Party — Commercialization Activity | 877,000 | USD | 0001439222-20-000039 |
| Q1 2020Quarterly · 2020-03-31 | Product | Collaboration Revenue Related Party — Research Services | 59,220,000 | USD | 0001439222-20-000039 |
| Q1 2020Quarterly · 2020-03-31 | Product | License And Service | 0 | USD | 0001439222-20-000039 |
| Q1 2020Quarterly · 2020-03-31 | Product | Product | 22,674,000 | USD | 0001439222-20-000039 |
| Q1 2020Quarterly · 2020-03-31 | Product | Royalty | 3,334,000 | USD | 0001439222-20-000039 |
| Q1 2020Quarterly · 2020-03-31 | Product | Service Other | 801,000 | USD | 0001439222-20-000039 |
| Q3 2019Quarterly · 2019-09-30 | Product | Collaboration Revenue Other — License And Service | -103,000 | USD | 0001439222-20-000069 |
| Q3 2019Quarterly · 2019-09-30 | Product | Collaboration Revenue Related Party — Commercialization Activity | 821,000 | USD | 0001439222-20-000069 |
| Q3 2019Quarterly · 2019-09-30 | Product | Collaboration Revenue Related Party — Research Services | 4,695,000 | USD | 0001439222-20-000069 |
| Q3 2019Quarterly · 2019-09-30 | Product | Product | 17,422,000 | USD | 0001439222-20-000069 |
| Q3 2019Quarterly · 2019-09-30 | Product | Royalty | 2,666,000 | USD | 0001439222-20-000069 |
| Q3 2019Quarterly · 2019-09-30 | Product | Service Other | 523,000 | USD | 0001439222-20-000069 |
| FY 2018Yearly · 2018-12-31 | Product | Collaboration Revenue Other | 12,670,000 | USD | 0001439222-21-000029 |
| FY 2018Yearly · 2018-12-31 | Product | Collaboration Revenue Related Party — Commercialization Activity | 3,744,000 | USD | 0001439222-21-000029 |
| FY 2018Yearly · 2018-12-31 | Product | Collaboration Revenue Related Party — Development Activities | 1,342,000 | USD | 0001439222-21-000029 |
| FY 2018Yearly · 2018-12-31 | Product | Collaboration Revenue Related Party — License And Service | 15,000,000 | USD | 0001439222-21-000029 |
| FY 2018Yearly · 2018-12-31 | Product | Collaboration Revenue Related Party — Research Services | 40,575,000 | USD | 0001439222-21-000029 |
| FY 2018Yearly · 2018-12-31 | Product | Committee Participation | 0 | USD | 0001439222-21-000029 |
| FY 2018Yearly · 2018-12-31 | Product | Product | 13,841,000 | USD | 0001439222-21-000029 |
| FY 2018Yearly · 2018-12-31 | Product | Royalty | 7,215,000 | USD | 0001439222-21-000029 |
| FY 2018Yearly · 2018-12-31 | Product | Service Other | 0 | USD | 0001439222-21-000029 |
| FY 2018Yearly · 2018-12-31 | Product | Service Other Non Performance Obligations | 230,000 | USD | 0001439222-21-000029 |
| FY 2017Yearly · 2017-12-31 | Product | Collaboration Revenue Other | 0 | USD | 0001439222-20-000014 |
| FY 2017Yearly · 2017-12-31 | Product | Collaboration Revenue Related Party — Commercialization Activity | 2,954,000 | USD | 0001439222-20-000014 |
| FY 2017Yearly · 2017-12-31 | Product | Collaboration Revenue Related Party — Committee Participation | 167,000 | USD | 0001439222-20-000014 |
| FY 2017Yearly · 2017-12-31 | Product | Collaboration Revenue Related Party — Research Services | 37,953,000 | USD | 0001439222-20-000014 |
| FY 2017Yearly · 2017-12-31 | Product | Development Activities | 0 | USD | 0001439222-20-000014 |
| FY 2017Yearly · 2017-12-31 | Product | License And Service | 0 | USD | 0001439222-20-000014 |
| FY 2017Yearly · 2017-12-31 | Product | Product | 0 | USD | 0001439222-20-000014 |
| FY 2017Yearly · 2017-12-31 | Product | Royalty | 1,937,000 | USD | 0001439222-20-000014 |
| FY 2017Yearly · 2017-12-31 | Product | Service Other | 0 | USD | 0001439222-20-000014 |
| FY 2017Yearly · 2017-12-31 | Product | Service Other Non Performance Obligations | 0 | USD | 0001439222-20-000014 |
| FY 2016Yearly · 2016-12-31 | Product | Collaboration Revenue Other | 0 | USD | 0001439222-19-000004 |
| FY 2016Yearly · 2016-12-31 | Product | Collaboration Revenue Related Party | 69,892,000 | USD | 0001439222-19-000004 |
| FY 2016Yearly · 2016-12-31 | Product | Product | 0 | USD | 0001439222-19-000004 |
| FY 2016Yearly · 2016-12-31 | Product | Royalty | 0 | USD | 0001439222-19-000004 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.